ClinicalTrials.gg
Sign In

Drug

Berberine ursodeoxycholate clinical trials

Also written HTD1801.

studies test it
11
open now
1
in phase 3
3
first study started
2018

Keep track of what changes. Save the berberine ursodeoxycholate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

berberine ursodeoxycholate
4

Development codes

HTD1801
9

Studies by the year they started

11 studies that test it; most in 2018 (3)

Studies that test berberine ursodeoxycholate, by start year
YearStudies
20183
20212
20222
20232
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
8
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2
4
Cholangitis, Sclerosing
2
Non-alcoholic Fatty Liver Disease
1
Liver Cirrhosis, Biliary
1
Hypercholesterolemia
1

Who runs them

Industry 10 · Other 1

HighTide Therapeutics (Hong Kong) Limited (6) · Shenzhen HighTide Biopharmaceutical Ltd. (4) · Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (1)

Studies

Open first, then newest update. How each study uses berberine ursodeoxycholate is read from its arms, and is right about nine times in ten.

Testing it · 11

Codes

What other systems call berberine ursodeoxycholate · ClinicalTrials.gg INT018260

  • UNII (FDA) VM8KQ3W8GMBERBERINE URSODEOXYCHOLATEOne source FDA
  • NCI Thesaurus C190490Berberine UrsodeoxycholateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.